Legal & General Group’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,972
| Closed | -$9K | – | 3543 |
|
|
2022
Q2 | $9K | Sell |
7,972
-3,010
| -27% | -$3.15K | ﹤0.01% | 3390 |
|
|
2022
Q1 | $12K | Hold |
10,982
| – | – | ﹤0.01% | 3376 |
|
|
2021
Q4 | $8K | Hold |
10,982
| – | – | ﹤0.01% | 3510 |
|
|
2021
Q3 | $10K | Hold |
10,982
| – | – | ﹤0.01% | 3450 |
|
|
2021
Q2 | $18K | Buy |
10,982
+3,495
| +47% | +$5.84K | ﹤0.01% | 3338 |
|
|
2021
Q1 | $16K | Hold |
7,487
| – | – | ﹤0.01% | 3231 |
|
|
2020
Q4 | $9K | Hold |
7,487
| – | – | ﹤0.01% | 3379 |
|
|
2020
Q3 | $9K | Sell |
7,487
-2,564
| -26% | -$3.12K | ﹤0.01% | 3284 |
|
|
2020
Q2 | $12K | Hold |
10,051
| – | – | ﹤0.01% | 3278 |
|
|
2020
Q1 | $8K | Hold |
10,051
| – | – | ﹤0.01% | 3211 |
|
|
2019
Q4 | $10K | Buy |
10,051
+1,917
| +24% | +$2.32K | ﹤0.01% | 3301 |
|
|
2019
Q3 | $11K | Hold |
8,134
| – | – | ﹤0.01% | 3260 |
|
|
2019
Q2 | $12K | Hold |
8,134
| – | – | ﹤0.01% | 3336 |
|
|
2019
Q1 | $12K | Hold |
8,134
| – | – | ﹤0.01% | 3226 |
|
|
2018
Q4 | $12K | Hold |
8,134
| – | – | ﹤0.01% | 3242 |
|
|
2018
Q3 | $15K | Hold |
8,134
| – | – | ﹤0.01% | 3273 |
|
|
2018
Q2 | $15K | Buy |
+8,134
| New | +$15.1K | ﹤0.01% | 3259 |
|
Legal & General Group's MBII Position: Q3 2022 in Review
Legal & General Group sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 7,972 shares — an estimated $9K sold.
Legal & General Group first reported a position in MBII in Q2 2018 and held it in 17 quarters. The position peaked at $18K in Q2 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- Legal & General Group reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- Legal & General Group sold 7,972 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $9K.
- Legal & General Group first reported a position in Marrone Bio Innovations, Inc. in Q2 2018 and held it in 17 quarters.
- Legal & General Group's Marrone Bio Innovations, Inc. position peaked at $18K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.